MEF2 is intimately associated with angiogenesis and scar formation. However, the mechanisms through which MEF2 is involved in these processes remain incompletely understood, necessitating further in-depth research at the genetic and molecular levels. An increasing number of studies suggest that MEF2 holds significant potential in anti-angiogenesis and scar treatment therapies, potentially emerging as a novel target for the treatment of pathological scars in the future.
Tao et al. (Sun,) studied this question.